⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DGX News
Quest Diagnostics Inc.
Quest Diagnostics to Speak at Citi's 2025 Global Healthcare Conference
prnewswire.com
DGX
New Study Demonstrates Accuracy of Two Quest AD-Detect® Tests for Alzheimer's Disease Diagnosis
prnewswire.com
DGX
MVZ HPH führt ctDNA-Bluttest zur Krebsüberwachung in Europa ein, basierend auf der Haystack MRD®-Technologie von Quest Diagnostics® USA - Deutsch USA - English
prnewswire.com
DGX
MVZ HPH Brings ctDNA Blood Test for Cancer Monitoring to Europe, Based on Haystack MRD® Technology from Quest Diagnostics®
prnewswire.com
DGX
Quest Diagnostics to Release Third Quarter 2025 Financial Results on October 21, 2025
prnewswire.com
DGX
Quest Diagnostics to Improve Laboratory Testing Experience with Industry-First Epic Collaboration
prnewswire.com
DGX
Haystack Oncology and Rutgers Cancer Institute Collaborate in a Clinical Study to Examine Haystack MRD as a Guide for Post-Surgical Treatment for Lung Cancer
prnewswire.com
DGX
Quest Diagnostics to Speak at the Jefferies Healthcare Services Conference
prnewswire.com
DGX
Corewell Health and Quest Diagnostics to Enter into Joint Venture Providing Enhanced Laboratory Services in Michigan
prnewswire.com
DGX
FDA Grants Breakthrough Device Designation for Haystack MRD Circulating Tumor DNA Test from Quest Diagnostics
prnewswire.com
DGX